News
Aducanumab Virtual Symposium
A symposium co-hosted by HBHI and the Hopkins Economics of Alzheimer's Disease and Services Center covers the ramifications of the approval of controversial Alzheimer's Disease drug Aduhelm for patients enrolled in approved clinical trials.